Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for the implantation of leadless pacemakers from the French Working Group on Cardiac Pacing and Electrophysiology of the French Society of Cardiology.
Defaye P, Klug D, Anselme F, Gras D, Hermida JS, Piot O, Alonso C, Fauchier L, Gandjbakhch E, Marijon E, Maury P, Taieb J, Boveda S, Sadoul N; French Working Group on Cardiac Pacing and Electrophysiology. Defaye P, et al. Among authors: hermida js. Arch Cardiovasc Dis. 2018 Jan;111(1):53-58. doi: 10.1016/j.acvd.2017.10.002. Epub 2017 Dec 6. Arch Cardiovasc Dis. 2018. PMID: 29221628 Free article. Review. No abstract available.
Guidelines issued by the French Society of Cardiology concerning the competence, performance and environment required in the practice of diagnostic and interventional cardiac electrophysiology.
Piot O, Anselme F, Bovéda S, Chauvin M, Daubert JC, Defaye P, Deharo JC, Gras D, Hermida JS, Kacet S, Klug D, Leenhardt A, le Heuzey JY, Mabo P, Pisapia A, Sadoul N, Salvador-Mazenq M, Cazeau S; Cardiac Rhythm and Pacing Group; French Society of Cardiology. Piot O, et al. Among authors: hermida js. Arch Cardiovasc Dis. 2011 Nov;104(11):586-90. doi: 10.1016/j.acvd.2011.09.002. Epub 2011 Nov 8. Arch Cardiovasc Dis. 2011. PMID: 22117911 Free article. No abstract available.
A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial.
Guédon-Moreau L, Lacroix D, Sadoul N, Clémenty J, Kouakam C, Hermida JS, Aliot E, Boursier M, Bizeau O, Kacet S; ECOST trial Investigators. Guédon-Moreau L, et al. Among authors: hermida js. Eur Heart J. 2013 Feb;34(8):605-14. doi: 10.1093/eurheartj/ehs425. Epub 2012 Dec 13. Eur Heart J. 2013. PMID: 23242192 Free PMC article. Clinical Trial.
Role of patient education in the perception and acceptance of home monitoring after recent implantation of cardioverter defibrillators: the EDUCAT study.
Laurent G, Amara W, Mansourati J, Bizeau O, Couderc P, Delarche N, Garrigue S, Guyomar Y, Hermida JS, Moïni C, Popescu E; EDUCAT registry investigators. Laurent G, et al. Among authors: hermida js. Arch Cardiovasc Dis. 2014 Oct;107(10):508-18. doi: 10.1016/j.acvd.2014.06.009. Epub 2014 Sep 11. Arch Cardiovasc Dis. 2014. PMID: 25218008 Free article.
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.
Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators. Marijon E, et al. Among authors: hermida js. Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330420 Free PMC article.
Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
Souissi Z, Boulé S, Hermida JS, Doucy A, Mabo P, Pavin D, Anselme F, Auquier N, Ninni S, Coisne A, Brigadeau F, Deken-Delannoy V, Klug D, Lacroix D. Souissi Z, et al. Among authors: hermida js. Europace. 2018 Feb 1;20(2):362-369. doi: 10.1093/europace/euw332. Europace. 2018. PMID: 28017936
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
Andorin A, Gourraud JB, Mansourati J, Fouchard S, le Marec H, Maury P, Mabo P, Hermida JS, Deharo JC, Delasalle B, Esnault S, Sadoul N, Davy JM, Leenhardt A, Klug D, Defaye P, Babuty D, Sacher F, Probst V. Andorin A, et al. Among authors: hermida js. Heart Rhythm. 2017 Aug;14(8):1147-1154. doi: 10.1016/j.hrthm.2017.04.019. Epub 2017 Apr 12. Heart Rhythm. 2017. PMID: 28411139 Clinical Trial.
Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.
Teiger E, Thambo JB, Defaye P, Hermida JS, Abbey S, Klug D, Juliard JM, Pasquie JL, Rioufol G, Lepillier A, Elbaz M, Horvilleur J, Brenot P, Pierre B, Le Corvoisier P; French National Left Atrial Appendage Closure Registry (FLAAC) Investigators. Teiger E, et al. Among authors: hermida js. Circ Cardiovasc Interv. 2018 Mar;11(3):e005841. doi: 10.1161/CIRCINTERVENTIONS.117.005841. Circ Cardiovasc Interv. 2018. PMID: 29540492 Free article.
107 results